Key point: Only 51.3% of patients treated with MPH had a documented diagnosis of ADHD, while the remainder were treated for depressive, substance-related, and personality disorders, highlighting frequent off-label use in acute settings.

In a victory for academic freedom and education equity, the U.S. Department of Education conceded the end of its February 14, 2025, “Dear Colleague” directive that sought to restrict diversity, equity, and inclusion (DEI) efforts in schools and higher education institutions nationwide.

Public conversations about disability are never neutral. When ADHD is framed as a social media trend, real people pay the price with delayed diagnoses and years of self-doubt

Merlin Entertainments has backtracked on its controversial plan to tighten access to its disability queuing system at its theme parks following strong criticism from people with autism, ADHD and anxiety. The company had planned to introduce new eligibility rules for its Ride Access Pass (RAP), which provides a non-queueing option for people unable to stand…

Letter writer is stuck in a frustrating cycle of constantly telling their son with ADHD to stop certain behaviors.

Azurity Pharmaceuticals has announced that lisdexamfetamine dimesylate (Arynta) oral solution will be available mid-2026 for treating attention-deficit/hyperactivity disorder (ADHD) in adults and pediatric patients aged 6 years and older.1 Arynta gained US Food and Drug Administration approval back on June 16, 2025, for the treatment of ADHD in adults and pediatric patients 6 years and…

A new campaign from Otsuka aims to educate healthcare professionals about the far-reaching impacts of attention-deficit/hyperactivity disorder (ADHD) on patients’ lives, beyond just the diagnostic symptoms of the condition.

Six in 10 Patients With Severe Borderline Personality Disorder Have Symptoms of ADHD Attention-deficit/hyperactivity disorder (ADHD) may be a common comorbid condition in patients with severe borderline personality disorder, a study in Psychiatric Research & Clinical Practice has found.

Key point: Genetically predicted ADHD was associated with higher BMI, increased odds of type 2 diabetes, and a greater likelihood of smoking initiation.

Key points: Women with ADHD experience more perimenopausal symptoms, and earlier in life. This link may be due to consequences of ADHD such as anxiety and lower socio economic status. More intense symptoms also come from the relationship between estrogen and ADHD. Interventions to reduce chronic stress could promise to alleviate some difficulties among women…

In a recent interview with Contemporary Pediatrics, Aldo A. Conti, PhD, MsC, BsC, CPsychol, research associate at King’s College London, discussed findings from a large, multicenter clinical trial evaluating the safety and efficacy of trigeminal nerve stimulation (TNS), a noninvasive brain stimulation device marketed for children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

A longitudinal study in Christchurch, New Zealand found that individuals who displayed the most severe ADHD symptoms as adolescents were at an elevated risk of developing substance use disorder, depression, and suicidal ideation in early adulthood. They were also more likely to engage in crime and be unemployed. These individuals tended to have lower income…